Objective To observe the effects of shenfu injection (SFI) on the awakening quality of the patients with hepatitis B cirrhosis undergoing splenectomy under general anethesia. Methods Forty patients with hepatitis B cirrhosis and hepatic insufficiency (ASA classⅡ~Ⅲ) underwent splenectomy by general anesthesia. Patients were all sent into the post-anesthesia care unit (PACU) shortly after the operation with unconscious and no spontaneously breathing. They were randomly divided into two groups: SFI treatment group (Group SFI, n =20) and normal saline controlled group (Group NSC, n = 20). SFI group were treated with SFI (1 mL/kg, i. v.) in 10 minutes, and NSC group were treated with normal saline (1 mL/kg,i.v.). The time of eyes opening, extubation of tracheal catheter and the detention time of PACU were recorded. The heart rate (HR) and the average artery presses (MAP) were monitored at 4 time points: before SFI and normal saline administration, 5 min, 15 min, and 45 min after administration. The incidence of restlessness during the patients awakening period was also recorded. Results The time of eyes opening, extubation and the detention time of PACU of SFI group show no significant difference compared with the NSC group (P > 0.05). SFI and normal saline intravenous injection did not cause significant changes on HR and MAP at the time of 5 min , 15 min and 45 min compared to the time of before administration (P > 0.05). The incidence of restlessness during the patients resuscitation period in SFI group were lower than in NSC group (P < 0.05). Conclusion Shenfu injection can effectively improve the awakening quality and decrease the incidence of restlessness of the patients with hepatitis B cirrhosis undergoing splenectomy under general anesthesia during the awakening period in PACU.

150?mol/L who underwent PTCA and/or coronary stenting were included (renal dysfunction group). Another 25 age and sex matched patients who had normal serum creatinine level and received coronary intervention at the same period were served as a control group. The status of coronary disease, procedural complications and long term prognosis were compared between the two groups. Results The number of patients with multi vessel disease (72% vs 48%, P

Objective To evaluate the clinical efficacy of cutting balloon angioplasty (CBA) for treating lesions in small coronary arteries. Methods The diameter for reference of coronary artery is less than 2.7mm which is considered as “small vessel”. CBA procedures were performed on 25 lesions in 22 patients. Results The procedure was successfully obtained in 21 lesions(84%). Seven severe stenotic lesions (diameter of stenosis≥90%) underwent dilatation with small conventional balloon(1.5 mm diameter). Bail out stenting was performed in 2 lesions because of severe dissections. Failure of cutting balloon to pass through the stenosis in one lesion. During follow up, 5 patients had recurrence of coronary angina and 3 of them underwent coronary angiography for check up, In stent restenosis (ISR) occurred in one patient, which was successfully redilated using CBA. One patient had total occlusion of the diagonal branch with ISR of LAD. One patient developed new lesion in other coronary artery.Conclusions CBA is safe and effective, and provides a new therapeutic strategy for lesions in the small coronary arteries.

75mmHg) underwent PBMV using standard Inoue technique, and the changes in clinical functional status and echo Doppler pulmonary systolic pressure during follow up were assessed. Results PBMV was successful in 39 patients. Immediately after the procedure, mitral valve area increased from (0.83?0.12)cm 2 to (1.75?0.11)cm 2 ,pulmonary systolic pressure decreased from (85?7)mmHg to (61?13)mmHg (all P

70%) underwent successful stent implantation. Two weeks after interventional treatment, renal function was improved in 26 patients and blood pressure was well controlled in 24.Conclusions Age, hypertension and hyperlipidemia are the factors influencing occurrence of RAS in patients with CAD. Stent implantation plays an important role in the protection of renal function and control of hypertension.

0.05), but hospitalization duration was shorter in the invasive group than in the conservative group (10.3?5.6 days vs 14.6?10.7 days, P

Objective To evaluate the feasibility, safety and efficacy of ACS MULTI LINK PENTA (PENTA) stent in patients with coronary artery disease.Methods From March to June 2002, thirty PENTA stents were implanted in 28 patients with 30 de novo lesions. For each patient the demographic, interventional and mean 3 month follow up informations were recorded. Results Almost two thirds of patients suffered from hypertension(61%) and half experienced unstable angina (53%). Most target lesions(67%) had unfavorable morphological characteristics (type B2 or C). No stent deployment failure occurred as well as acute or subacute stent thromobis.The major branches compromised after stenting were only in 2 patients. During floow up,no MACE occurred, except reoccurrence of chest pain in 2 patients (7%). Conclusions The PENTA stent appears to be safe and effective in treating coronary artery disease.

Objective To evaluate the therapeutic efficacy of intra aortic balloon supporting in coronary interventions for high risk patients with coronary artery disease(CAD).Methods Sixteen high risk CAD patients accepted percutaneous coronary intervention assisted by intra aortic balloon pumping together with clinical variables, procedural and follow up informations were recorded and evaluated. Results All patients presented with severe left ventricular dysfunction, multi vessel disease and high jeopardy scores. 12 patients acquired complete revascularization. Mean duration of balloon pumping was (31?17) minutes. Aortic diastolic and mean pressures were increased during balloon pumping [diastolic:(69?11)mmHg pre.vs (131?15)mmHg post.; mean:(82?13)mmHg pre.vs (111?7)mmHg post., P

Objective To compare the clinical utility of s7 and s670 intracoronary sents in the management of patients with coronary artery disease. Methods The clinical follow-up outcomes of 68 patients after implantation of s7 (n=32; group Ⅰ) and s670 (n=36;group Ⅱ) intracoronary stents were retrospectively analysed. Results The successful procedure rates were 100% in group Ⅰ and 97.2% in groupⅡ. The follow-up period was six months for both groups. In group Ⅰ, there were no death, no re-infarction and no revascularization but 2 patients experienced reccurrence of angina ( 6.25%). In group Ⅱ, there were 1 death, 1 patient undergoing revascularization, 3 patients suffering from reccurrence of angina ( 13.8%). Conclusions Both s7 and s670 intracoronary stents appear to be safe and effective in the treatment of coronary lesions with favorable outcomes.

Objective To assess the influence on